Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma

Human Pathology

Volumn 34, Issue 9, 2003, Pages 893-901

  Montironi, Rodolfo ^a   Scarpelli, Marina ^b   Mazzucchelli, Roberta ^b   Hamilton, Peter W ^b   Thompson, Deborah ^b   Ranger Moore, James ^b   Bostwick, David G ^b   Bartels, Peter H ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b NONE

Author keywords

Carcinoma in situ; Dysplasia; Malignancy associated change; Urothelial hyperplasia; Urothelial papillary carcinoma; Urothelium

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER MUCOSA; CANCER GRADING; CELL NUCLEUS; CHROMATIN; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; HUMAN; HUMAN TISSUE; KARYOMETRY; MALE; PAPILLARY CARCINOMA; PHENOTYPE; PROSTATE DISEASE; QUANTITATIVE ANALYSIS; STAINING; SYNCHRONOUS PAPILLARY CARCINOMA; TISSUE PREPARATION; UROTHELIAL PAPILLARY CARCINOMA; UROTHELIUM; WORLD HEALTH ORGANIZATION;

EID: 0141429120     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00341-1     Document Type: Article

References (41)

1. Bostwick DG, Mikuz G: Urothelial papillary (exophytic) neoplasms. Virchows Arch 441:109-116, 2002
2. Lopez-Beltran A, Cheng L, Anderson L, et al: Preneoplastic non-papillary lesions and conditions of the urinary bladder: An update based on the Ancona International Consultation. Virchows Arch 440:3-11, 2002
3. Cheng L, Cheville JC, Neumann RM, et al: Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 23:443-447, 1999
4. Cheng L, Cheville JC, Neumann RM, et al: Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85:2469-2474, 1999
5. Wolf H, Hojgaard K: Urothelial dysplasia in random mucosal biopsies from patients with bladder tumors. Scand J Urol Nephrol 14:3741, 1980
6. Althusen AF, Prout GRJ, Dal JJ: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116: 575-580, 1976
7. Smith G, Elton RA, Beynon LL: Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. Br J Urol 55:665-669, 1983
8. Hartmann A, Schlake G, Zaak D, et al: Occurrence of chromosome 9 and p53 alteration in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 62:809-818, 2002
9. Bostwick DG, Lopez-Beltran A: Bladder Biopsy Interpretation. New York, United Pathologist Press, 1999
10. Bostwick DG, Ramnani D, Cheng L: Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 26:493-507, 1999
11. Baud E, Catilina P, Boitux JP, et al: Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion. In J Cancer 77:821-824, 1998
12. Hartmann A, Moser K, Kriegmair M, et al: Frequent genetic alterations in simple urothelial hyperplasia of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 154:721-727, 1999
13. Baithun SI, Naase M, Blanes A, et al: Molecular and kinetic features of transitional cell carcinomas of the bladder: Biological and clinical implications. Virchows Arch 438:289-297, 2001
14. Czerniak B, Li L, Chaturvedi V, et al: Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 27:392402, 2000
15. Standler WM, Steinberg G, Yang X, et al: Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization. Clin Cancer Res 7:1676-1682, 2001
16. Gontijo AM, Marcondes JP, Nunes Elias F, et al: DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma. Environ Mol Mutagen 40:190-199, 2002
17. Mostofi FK, Sorbin LH, Torloni H: Histological Typing of Urinary Bladder Tumours. International Classification of Tumours, Vol 19. Geneva, Switzerland, World Health Organization, 1973
18. Sobin LH, Wittekind CH: TNM. Classification of Malignant Tumors, ed 6. New York, Wiley, 2002
19. Koss LG: Tumors of the Urinary Bladder. Atlas of Tumor Pathology, Vol 11 (Second Series). Washington, DC, Armed Forces Institute of Pathology, 1975
20. Murphy WM, Beckwith JB, Farrow GM: Tumors of the Kidney, Bladder, and Related Urinary Structures. Atlas of Tumor Pathology, Vol 11 (Third Series). Washington, DC, Armed Forces institute of Pathology, 1994
21. Bahr GF, Bartels PH, Bibbo M, et al: Evaluation of the papanicolaou stain for computer-assisted cellular pattern recognition. Acta Cytol 17:106-112, 1973
22. Keenan S, Diamond J, McCluggage G, et al: Nuclear chromatin texture in the grading of cervical intraepithelial neoplasia (CIN). Cytometry 11(suppl):116, 2002
23. Haralick RM, Shamugam K, Dinstein I: Textural features for image classification. IEEE Trans Man Cybernet 3:610-621, 1973
24. Galloway M: Texture analysis using gray-level run lengths. Comp Graph Image Process 4:172-179, 1975
25. Young T, Verbeek PW, Mayall B: Characterization of chromatin distributions in cell nuclei. Cytometry 7:467474, 1986
26. Bartels PH, Montironi RM, Bostwick D, et al: Karyometry of secretory cell nuclei in high-grade PIN lesions. Prostate 48:144-155, 2001
27. Kruskal WH, Wallis WA: Use of ranks on one-criterion variance analysis. J Am Stat Assoc 47:583-621, 1952
28. Bartels PH, Olson GB: Computer analysis of lymphocyte images, in Catsimpoolas N (ed): Methods of Cell Separation, Vol 3. New York, Plenum Press, 1980, 1-99
29. Beale EM: Euclidean cluster analysis. Bull Int Stat Inst 43: 2143, 1969
30. SAS Institute, Inc: SAS System for Windows, Version 8.1. Cary, NC, SAS Institute, Inc
31. Bartels PH, Duval da Silva V, Montironi R, et al: Chromatin texture signature in nuclei from prostate lesions. Anal Quant Cytol Histol 20:407-716, 1998
32. Colley WW, Lohnes PR: Multivariate Data Analysis. New York, Wiley, 1971
33. Montironi R, Scarpelli M, Sisti S, et al: Quantitative analysis and malignancy progression of the papillary neoplasia of urinary bladder. Pathol Res Pract 182:528-529, 1987
34. Bol MGW, Baak JPA, Janssen EAM, et al: Further testing of morphometric grading in Ta/1 urothelial carcinomas of the urinary bladder and additional value of p53 immunoquantitation. Anal Quant Cytol Histol 24:114-120, 2002
35. Gschwendtner A, Hoffmann-Weltin Y, Mikuz G, et al: Quantitative assessment of bladder cancer by nuclear texture analysis using automated high-resolution image cytometry. Mod Pathol 12:806-813, 1999
36. Muto S, Horie S, Takahashi S, et al: Genetic and epigenetic alterations in normal epithelium in patients with metachronous bladder cancer. Cancer Res 60:4021-4025, 2000
37. Sherman AB, Koss LG: Morphometry of benign urothelial cells in the presence of cancer. Anal Quant Cytol Histol 5:221, 1983
38. Nieburgs H: Malignancy-associated cellular markers, in Wied GL, Keebler CM, Koss LG (eds): Compendium on Diagnostic Cytology, ed 7, Tutorials of Cytology. Chicago, IL, 1992, pp 409418
39. MacAulay C, Payne P, Wilton D, et al: MAC: Some answers, more questions [abstract]. Anal Quant Cytol Histol 19:78A, 1996
40. Dairkee SH: Allelic loss in normal lobules adjacent to breast cancer [abstract]. Cancer Detect Prev 22(Suppl 1):135A, 1998
41. Montironi R, Longato Filho A, Santinelli A, et al: Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer: Morphometric analysis in whole-mount sections. Virchows Arch 437: 625-634, 2000